Physician

Ren Zhang, M.D.

According to 2025 Medicare claims, Ren Zhang, M.D. (NPI: 1114909181) practices cardiology in the Abilene, TX market, with the plurality of this provider's patient population coming from Taylor, TX. This provider's primary affiliated billing organization is HENDRICK PROVIDER NETWORK (NPI: 1396961322; TIN: 752660403) and primary practice location at 79601-2432. Zhang is affiliated with the Main Street Rural Health Magnolia ACO LLC (ACO ID: A5400) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Zhang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 3,181 traditional Medicare patients, billed 9,429 HCPCS/CPT codes, and received $287,940 in Medicare payments. The top billing code was 75574 (Ct scan of blood vessels and grafts of heart with contrast). Part D data shows 5,551 prescription claims across 763 beneficiaries totaling $1,234,402 in drug costs, led by Eliquis (Apixaban). 2020 DME data shows 11 claims. Open Payments data shows 52 records totaling $50,042. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $383,509 to $1,234,402. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $13,585 and ending at $24,755.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,886	12,449	$355,844
2016	3,085	12,329	$368,783
2017	3,186	12,081	$369,171
2018	3,033	17,060	$412,469
2019	3,033	15,692	$407,763
2020	2,530	13,020	$323,711
2021	2,356	10,656	$326,111
2022	2,912	11,933	$342,461
2023	3,004	11,274	$330,069
2024	3,181	9,429	$287,940

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	606	7,478	$383,509
2016	641	8,843	$478,731
2017	759	9,012	$586,681
2018	657	7,655	$620,527
2019	678	6,724	$802,871
2020	647	6,242	$892,223
2021	725	5,745	$940,180
2022	776	6,064	$1,182,561
2023	752	5,796	$1,270,412
2024	763	5,551	$1,234,402

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	52	$5,187
2016	N/R	14	$1,062
2017	N/R	42	$2,255
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	11	$24,575
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
75574	Ct scan of blood vessels and grafts of heart with contrast	302	302	$81
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	442	593	$63
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	940	966	$47
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	377	409	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	973	1,179	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	529	27,491	$522,626
Entresto	Sacubitril/Valsartan	239	13,989	$306,886
Repatha Sureclick	Evolocumab	79	4,140	$75,363
Xarelto	Rivaroxaban	62	3,610	$63,482
Farxiga	Dapagliflozin Propanediol	75	3,527	$63,267

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	48	$2,879	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	4	$47,163	Cleerly, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ren Zhang, M.D.?

Tedicare shows public-source Medicare data for Ren Zhang, M.D. (NPI 1114909181), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ren Zhang, M.D. have ACO affiliation data?

Ren Zhang, M.D. is shown with ACO affiliation data for Main Street Rural Health Magnolia ACO LLC (MSSP, ACO ID A5400) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Ren Zhang, M.D.?

Ren Zhang, M.D. is linked to HENDRICK PROVIDER NETWORK (billing NPI 1396961322) in the available physician profile data.

Does Ren Zhang, M.D. have Open Payments data?

Ren Zhang, M.D. has 52 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.